[HTML][HTML] Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway
Q Xu, N Wu, X Li, C Guo, C Li, B Jiang, H Wang… - Cell death & …, 2019 - nature.com
Pancreatic cancer is a highly malignant cancer and lacks effective therapeutic targets.
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway
Q Xu, N Wu, X Li, C Guo, C Li, B Jiang… - Cell Death and …, 2019 - search.proquest.com
Pancreatic cancer is a highly malignant cancer and lacks effective therapeutic targets.
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway
Q Xu, N Wu, X Li, C Guo, C Li, B Jiang… - Cell death & …, 2019 - pubmed.ncbi.nlm.nih.gov
Pancreatic cancer is a highly malignant cancer and lacks effective therapeutic targets.
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
[PDF][PDF] Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway
Q Xu, N Wu, X Li, C Guo, C Li, B Jiang, H Wang, D Shi - 2019 - scienceopen.com
Pancreatic cancer is a highly malignant cancer and lacks effective therapeutic targets.
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway.
Q Xu, N Wu, X Li, C Guo, C Li, B Jiang… - Cell Death & …, 2019 - europepmc.org
Pancreatic cancer is a highly malignant cancer and lacks effective therapeutic targets.
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway.
Q Xu, N Wu, X Li, C Guo, C Li, B Jiang… - Cell Death & …, 2019 - search.ebscohost.com
Pancreatic cancer is a highly malignant cancer and lacks effective therapeutic targets.
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
[HTML][HTML] Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway
Q Xu, N Wu, X Li, C Guo, C Li, B Jiang… - Cell Death & …, 2019 - ncbi.nlm.nih.gov
Pancreatic cancer is a highly malignant cancer and lacks effective therapeutic targets.
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …
Protein-tyrosine phosphatase 1B (PTP1B), a validated therapeutic target for diabetes and …